内镜胃折叠术:灵活、量身定制的减肥手术替代方案。

IF 0.8 Q4 SURGERY
Francesco Frattini, Andrea Gambetti, Giuseppe Cordaro, Jerry Spisani, Georgios Lianos, Bertoli Simona, Gianlorenzo Dionigi
{"title":"内镜胃折叠术:灵活、量身定制的减肥手术替代方案。","authors":"Francesco Frattini, Andrea Gambetti, Giuseppe Cordaro, Jerry Spisani, Georgios Lianos, Bertoli Simona, Gianlorenzo Dionigi","doi":"10.52198/23.STI.43.GS1745","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Endoscopic procedures are expanding and have been evolving in recent years, increasing their volume along with the development of new devices. This is due to the low morbidity and complication rate, the reversibility of the procedures, and the positive impact on patients. Among the endoscopic procedures gaining interest is sleeve gastroplasty. It emerged as a feasible and safe alternative to traditional bariatric surgery. There are no guidelines available on the indications and use of endoscopic gastroplasty. The aim of this study is to present preliminary results of a case series of endoscopic gastric plication procedures performed for different options: as a primary endoscopic sleeve, as revision for sleeve gastrectomy, and as revision for gastric bypass.</p><p><strong>Materials and methods: </strong>A retrospective analysis was performed on a prospective database collecting data on all patients with obesity treated with endoscopic gastroplasty with the Overstitch™ (Apollo Endosurgery, Inc., Austin, Texas) device from 2022 to 2023 in the bariatric surgery unit.</p><p><strong>Results: </strong>Twenty-three patients were treated from May 2022 to July 2023 with endoscopic gastric plication. Ten patients (43%) were submitted to primary endoscopic sleeve gastroplasty, three patients to revision of sleeve gastrectomy, one patient to revision of one anastomosis gastric bypass, and eight patients received a revision of Roux-en-Y gastric bypass. The body mass index (BMI) of patients submitted to primary ESG ranged from 33 to 42kg/m2, with a mean BMI of 37kg/m2. The age of the patients ranged from 22 to 70 years, with a mean age of 45. In one case, we registered a Clavien-Dindo 2 complication-an inflammatory perigastric reaction without a collection occurred 15 days after a primary ESG.</p><p><strong>Conclusion: </strong>Endoscopic gastric plication is emerging as a safe, mini-invasive, and effective procedure alternative to sleeve gastrectomy in patients with I or II class obesity or for those unfit for bariatric surgery. The endoscopic suturing device can be used both as a primary procedure or as a revisional option after failure of the primary surgery, thus proving to be a versatile option to provide to bariatric patients.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endoscopic Gastric Plication: A Flexible and Tailored Alternative to Bariatric Surgery.\",\"authors\":\"Francesco Frattini, Andrea Gambetti, Giuseppe Cordaro, Jerry Spisani, Georgios Lianos, Bertoli Simona, Gianlorenzo Dionigi\",\"doi\":\"10.52198/23.STI.43.GS1745\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Endoscopic procedures are expanding and have been evolving in recent years, increasing their volume along with the development of new devices. This is due to the low morbidity and complication rate, the reversibility of the procedures, and the positive impact on patients. Among the endoscopic procedures gaining interest is sleeve gastroplasty. It emerged as a feasible and safe alternative to traditional bariatric surgery. There are no guidelines available on the indications and use of endoscopic gastroplasty. The aim of this study is to present preliminary results of a case series of endoscopic gastric plication procedures performed for different options: as a primary endoscopic sleeve, as revision for sleeve gastrectomy, and as revision for gastric bypass.</p><p><strong>Materials and methods: </strong>A retrospective analysis was performed on a prospective database collecting data on all patients with obesity treated with endoscopic gastroplasty with the Overstitch™ (Apollo Endosurgery, Inc., Austin, Texas) device from 2022 to 2023 in the bariatric surgery unit.</p><p><strong>Results: </strong>Twenty-three patients were treated from May 2022 to July 2023 with endoscopic gastric plication. Ten patients (43%) were submitted to primary endoscopic sleeve gastroplasty, three patients to revision of sleeve gastrectomy, one patient to revision of one anastomosis gastric bypass, and eight patients received a revision of Roux-en-Y gastric bypass. The body mass index (BMI) of patients submitted to primary ESG ranged from 33 to 42kg/m2, with a mean BMI of 37kg/m2. The age of the patients ranged from 22 to 70 years, with a mean age of 45. In one case, we registered a Clavien-Dindo 2 complication-an inflammatory perigastric reaction without a collection occurred 15 days after a primary ESG.</p><p><strong>Conclusion: </strong>Endoscopic gastric plication is emerging as a safe, mini-invasive, and effective procedure alternative to sleeve gastrectomy in patients with I or II class obesity or for those unfit for bariatric surgery. The endoscopic suturing device can be used both as a primary procedure or as a revisional option after failure of the primary surgery, thus proving to be a versatile option to provide to bariatric patients.</p>\",\"PeriodicalId\":22194,\"journal\":{\"name\":\"Surgical technology international\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2023-12-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical technology international\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52198/23.STI.43.GS1745\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical technology international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52198/23.STI.43.GS1745","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

简介近年来,内窥镜手术不断扩展和发展,随着新设备的开发,手术量也在增加。这是因为内窥镜手术的发病率和并发症发生率低、可逆性强,而且对患者有积极的影响。在内窥镜手术中,袖状胃成形术越来越受到关注。它是传统减肥手术的一种可行且安全的替代方法。目前还没有关于内镜胃成形术适应症和使用的指南。本研究的目的是介绍内镜胃成形术的初步结果,该手术有不同的选择:内镜袖状胃成形术、袖状胃切除术的翻修术和胃旁路术的翻修术:对一个前瞻性数据库进行了回顾性分析,该数据库收集了2022年至2023年在减肥手术室使用Overstitch™(Apollo Endosurgery, Inc.,德克萨斯州奥斯汀)设备进行内镜胃成形术治疗的所有肥胖症患者的数据:2022年5月至2023年7月,23名患者接受了内镜胃成形术治疗。10名患者(43%)接受了初级内镜袖状胃成形术,3名患者接受了袖状胃切除术的改良,1名患者接受了单吻合胃旁路术的改良,8名患者接受了Roux-en-Y胃旁路术的改良。接受初治 ESG 的患者体重指数(BMI)从 33kg/m2 到 42kg/m2 不等,平均体重指数为 37kg/m2。患者的年龄从 22 岁到 70 岁不等,平均年龄为 45 岁。在一个病例中,我们发现了 Clavien-Dindo 2 并发症--在初治 ESG 术后 15 天出现了胃周炎症反应,但没有集结:结论:对于 I、II 级肥胖症患者或不适合接受减肥手术的患者来说,内镜胃成形术正在成为袖状胃切除术的一种安全、微创、有效的替代手术。内镜缝合装置既可作为初治手术,也可作为初治手术失败后的复诊选择,因此被证明是提供给减肥患者的一种多功能选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Endoscopic Gastric Plication: A Flexible and Tailored Alternative to Bariatric Surgery.

Introduction: Endoscopic procedures are expanding and have been evolving in recent years, increasing their volume along with the development of new devices. This is due to the low morbidity and complication rate, the reversibility of the procedures, and the positive impact on patients. Among the endoscopic procedures gaining interest is sleeve gastroplasty. It emerged as a feasible and safe alternative to traditional bariatric surgery. There are no guidelines available on the indications and use of endoscopic gastroplasty. The aim of this study is to present preliminary results of a case series of endoscopic gastric plication procedures performed for different options: as a primary endoscopic sleeve, as revision for sleeve gastrectomy, and as revision for gastric bypass.

Materials and methods: A retrospective analysis was performed on a prospective database collecting data on all patients with obesity treated with endoscopic gastroplasty with the Overstitch™ (Apollo Endosurgery, Inc., Austin, Texas) device from 2022 to 2023 in the bariatric surgery unit.

Results: Twenty-three patients were treated from May 2022 to July 2023 with endoscopic gastric plication. Ten patients (43%) were submitted to primary endoscopic sleeve gastroplasty, three patients to revision of sleeve gastrectomy, one patient to revision of one anastomosis gastric bypass, and eight patients received a revision of Roux-en-Y gastric bypass. The body mass index (BMI) of patients submitted to primary ESG ranged from 33 to 42kg/m2, with a mean BMI of 37kg/m2. The age of the patients ranged from 22 to 70 years, with a mean age of 45. In one case, we registered a Clavien-Dindo 2 complication-an inflammatory perigastric reaction without a collection occurred 15 days after a primary ESG.

Conclusion: Endoscopic gastric plication is emerging as a safe, mini-invasive, and effective procedure alternative to sleeve gastrectomy in patients with I or II class obesity or for those unfit for bariatric surgery. The endoscopic suturing device can be used both as a primary procedure or as a revisional option after failure of the primary surgery, thus proving to be a versatile option to provide to bariatric patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
141
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信